Buy or sell Benchling stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Benchling Stock

Benchling is a cloud-based software platform for biology researchers and research and development organizations.

About Benchling Stock

Benchling is the modern software platform purpose-built for life science R&D. Hundreds of thousands of scientists using cutting-edge techniques like CRISPR, CAR-T immunotherapy, and genetic engineering depend on our suite of cloud applications to design DNA, collaborate on experiments, manage research workflows, and make critical R&D decisions. Benchling is powering breakthrough research on biotherapeutics, biofuels, and biomaterials at leading life science companies and the world's most renowned academic labs. The company is focusing on life science collaboration, both private and public, through creating cloud-based software tools for digital DNA sequence editing, designing and running experiments, analyzing data, and sharing research. Benchling software includes an electronic lab notebook that allows researchers to document their experiments. It was founded in 2012, and is headquartered in San Francisco, California, United States.

Funding History

January 2015$6.1M
April 2016$7.0M
March 2018$18.2M
April 2019$37.0M
March 2020$50.5M
March 2021$200M


Head of Customer Support / CX Operations

Heather Fralich

Co-Founder & CEO

Sajith Wickramasekara

Chief Marketing Officer

Kaiser Mulla-Feroze

Product Manager

Alexandra Yorke

Product Manager

Reed Molbak


Joshua Ma


Ashutosh Singhal


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Benchling or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: